Portfolio Holdings Detail for ISIN IE0031442068

Stock Name / Fund	iShares Core S&P 500 UCITS ETF USD (Dist)
Issuer	Blackrock
Entity holding fund	iShares Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300YDM1GFZR5B4U80
ETF Ticker	IDUS(USD) LSE
ETF Ticker	IDUS.LS(USD) CXE
ETF Ticker	IUSA.AS(EUR) CXE
ETF Ticker	IUSA.DE(EUR) CXE
ETF Ticker	IUSA.LS(GBX) CXE
ETF Ticker	IUSA.MI(EUR) CXE
ETF Ticker	IUSAz(USD) CXE
ETF Ticker	IUSA(EUR) ETF Plus
ETF Ticker	IDUS.L(GBP) LSE

Holdings detail for SYK

Show aggregate SYK holdings

News associated with SYK

Noteworthy ETF Inflows: VUG, BSX, SYK, APH

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Growth ETF (Symbol: VUG) where we have detected an approximate $1.9 billion dollar inflow -- that's a 1.0% increase week over week in outsta - 2025-09-09 11:51:27

Stryker Corporation (NYSE:SYK) Receives $430.10 Consensus Target Price from Brokerages

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nineteen ratings firms that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average […] - 2025-09-08 02:50:50

Analysts Set Stryker Corporation (NYSE:SYK) Price Target at $430.10

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nineteen brokerages that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year price […] - 2025-08-14 02:48:56

The Health Care Select Sector SPDR Fund Experiences Big Outflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $547.2 million dollar outflow -- that's a 1.7% decrease - 2025-08-12 11:56:08

4 GARP Stocks That Investors Can Scoop Up for Maximum Returns

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RL, SYK, RGLD and ADSK hold promise. - 2025-08-12 11:44:00

Noteworthy ETF Outflows: XLV, PFE, SYK, DHR

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $190.1 million dollar outflow -- that's a 0.6% decrease - 2025-08-04 11:50:53

After-Hours Earnings Report for July 31, 2025 : AAPL, AMZN, SYK, KLAC, MSTR, COIN, AJG, NET, RMD, MPWR, IR, LPLA

The following companies are expected to report earnings after hours on 07/31/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Apple Inc. (AAPL)is reporting for the quarter ending June 30, 2025. The computer company's consensus earnings per share fo - 2025-07-31 15:00:01

See Which Of The Latest 13F Filers Holds SYK

At Holdings Channel, we have reviewed the latest batch of the 28 most recent 13F filings for the 06/30/2025 reporting period, and noticed that Stryker Corp (Symbol: SYK) was held by 12 of these funds. When hedge fund managers appear to be thinking alike, we find it is a good ide - 2025-07-24 12:22:30

Noteworthy ETF Inflows: SCHX, HON, SYK, PANW

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab US Large-Cap ETF (Symbol: SCHX) where we have detected an approximate $119.3 million dollar inflow -- that's a 0.2% increase week over week in - 2025-07-24 11:48:21

Should You Buy or Sell Boston Scientific Stock Ahead of Its Upcoming Earnings?

Boston Scientific (NYSE:BSX) is scheduled to report its earnings on Wednesday, July 23, 2025. - 2025-07-23 16:13:59

Stryker Corporation (NYSE:SYK) Stock Position Raised by Edgestream Partners L.P.

Edgestream Partners L.P. boosted its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 27.0% during the 1st quarter, HoldingsChannel reports. The firm owned 893 shares of the medical technology company’s stock after buying an additional 190 shares during the quarter. Edgestream Partners L.P.’s holdings in Stryker were worth $332,000 at the end […] - 2025-07-21 04:56:50

Fund Update: GREENLEAF TRUST Just Disclosed New Holdings

GREENLEAF TRUST just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-07-17 18:15:54

Should You Buy or Sell Abbott Laboratories Stock Ahead of Its Upcoming Earnings?

Abbott Laboratories (NYSE:ABT) is set to release its second-quarter earnings on Thursday, July 17, 2025. For event-driven traders, analyzing the stock’s historical reactions to earnings reports can provide valuable insights. - 2025-07-16 02:32:25

Allspring Global Investments Holdings LLC Sells 1,093 Shares of Stryker Corporation (NYSE:SYK)

Allspring Global Investments Holdings LLC reduced its stake in Stryker Corporation (NYSE:SYK – Free Report) by 2.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,368 shares of the medical technology company’s stock after selling 1,093 shares during the quarter. Allspring Global […] - 2025-07-03 05:31:05

Wednesday Sector Leaders: Technology & Communications, Healthcare

Looking at the sectors faring best as of midday Wednesday, shares of Technology & Communications companies are outperforming other sectors, losing just 0.2%. Within that group, Super Micro Computer Inc (Symbol: SMCI) and NVIDIA Corp (Symbol: NVDA) are two large stocks leadin - 2025-06-25 15:51:09

Analysts Set Stryker Corporation (NYSE:SYK) Target Price at $427.30

Shares of Stryker Corporation (NYSE:SYK – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nineteen research firms that are presently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating on the company. The average twelve-month target price […] - 2025-06-25 02:44:54

Advisor Resource Council Acquires New Stake in Stryker Corporation (NYSE:SYK)

Advisor Resource Council bought a new position in Stryker Corporation (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 848 shares of the medical technology company’s stock, valued at approximately $316,000. Several other institutional investors and hedge funds […] - 2025-06-24 05:22:59

The Implied Analyst 12-Month Target For IVW

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:46:08

Robertson Stephens Wealth Management LLC Sells 284 Shares of Stryker Corporation (NYSE:SYK)

Robertson Stephens Wealth Management LLC lowered its holdings in Stryker Corporation (NYSE:SYK – Free Report) by 30.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 641 shares of the medical technology company’s stock after selling 284 shares during the quarter. Robertson Stephens Wealth Management LLC’s holdings in Stryker were worth $239,000 as of its […] - 2025-06-20 05:41:07

Stryker (NYSE:SYK) versus NAYA Biosciences (NASDAQ:NAYA) Financial Contrast

NAYA Biosciences (NASDAQ:NAYA – Get Free Report) and Stryker (NYSE:SYK – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Profitability This table compares NAYA Biosciences and Stryker’s net […] - 2025-06-20 04:26:53

Exchange Traded Concepts LLC Purchases 429 Shares of Stryker Corporation (NYSE:SYK)

Exchange Traded Concepts LLC lifted its position in shares of Stryker Corporation (NYSE:SYK – Free Report) by 6.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,692 shares of the medical technology company’s stock after purchasing an additional 429 […] - 2025-06-18 07:36:50

Trust Point Inc. Sells 894 Shares of Stryker Corporation (NYSE:SYK)

Trust Point Inc. reduced its stake in shares of Stryker Corporation (NYSE:SYK – Free Report) by 47.4% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 991 shares of the medical technology company’s stock after selling 894 shares during the period. Trust Point Inc.’s holdings in Stryker […] - 2025-06-18 05:11:09

Stryker Co. (NYSE:SYK) Shares Acquired by Ritholtz Wealth Management

Ritholtz Wealth Management raised its holdings in shares of Stryker Co. (NYSE:SYK – Free Report) by 5.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,598 shares of the medical technology company’s stock after acquiring an additional 276 shares during the quarter. […] - 2025-06-17 07:38:45

Dynamic Advisor Solutions LLC Takes Position in Stryker Co. (NYSE:SYK)

Dynamic Advisor Solutions LLC purchased a new stake in shares of Stryker Co. (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 6,388 shares of the medical technology company’s stock, valued at approximately $2,378,000. Several other hedge funds and other […] - 2025-06-17 05:46:52

Buy, Sell, Or Hold Boston Scientific Stock At $100?

Boston Scientific (NYSE:BSX) has seen its stock price surge over 30% in the past twelve months, significantly outpacing the S&P 500’s 9% gain. This impressive performance is attributed to new product launches, which have bolstered sales growth and expanded profit margin - 2025-06-17 03:35:45

Assenagon Asset Management S.A. Buys 110 Shares of Stryker Co. (NYSE:SYK)

Assenagon Asset Management S.A. lifted its stake in Stryker Co. (NYSE:SYK – Free Report) by 1.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,375 shares of the medical technology company’s stock after purchasing an additional 110 shares during […] - 2025-06-16 05:06:59

Focus Financial Network Inc. Takes $214,000 Position in Stryker Co. (NYSE:SYK)

Focus Financial Network Inc. purchased a new stake in Stryker Co. (NYSE:SYK – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 576 shares of the medical technology company’s stock, valued at approximately $214,000. A number of other hedge funds and […] - 2025-06-15 05:58:52

5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough. - 2025-06-11 06:00:00

Vest Financial LLC Acquires New Holdings in Stryker Co. (NYSE:SYK)

Vest Financial LLC bought a new position in Stryker Co. (NYSE:SYK – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 545 shares of the medical technology company’s stock, valued at approximately $203,000. Other institutional investors and hedge funds have also bought and sold shares […] - 2025-06-09 05:51:03

Notable ETF Outflow Detected - IXJ, SYK, DHR, MDT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Global Healthcare ETF (Symbol: IXJ) where we have detected an approximate $116.0 million dollar outflow -- that's a 3.0% decrease week over - 2025-06-03 12:36:10

iShares Core S&P 500 UCITS ETF USD (Dist) SYK holdings

Date	Number of SYK Shares Held	Base Market Value of SYK Shares	Local Market Value of SYK Shares	Change in SYK Shares Held	Change in SYK Base Value	Current Price per SYK Share Held	Previous Price per SYK Share Held
2025-11-11 (Tuesday)	120,696	USD 43,897,135	USD 43,897,135	-92	USD 1,014,979	USD 363.7	USD 355.02
2025-11-10 (Monday)	120,788	USD 42,882,156	USD 42,882,156	-276	USD 48,502	USD 355.02	USD 353.81
2025-11-06 (Thursday)	121,064	USD 42,833,654	USD 42,833,654	-92	USD -1,098,723	USD 353.81	USD 362.61
2025-11-04 (Tuesday)	121,156	USD 43,932,377	USD 43,932,377	-184	USD 706,215	USD 362.61	USD 356.24
2025-10-31 (Friday)	121,340	USD 43,226,162	USD 43,226,162

Share Trades of SYK by Blackrock for IE0031442068

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-11	SELL	-92			363.700*		377.96 Profit of 34,772 on sale
2025-11-10	SELL	-276			355.020*		378.07 Profit of 104,347 on sale
2025-11-06	SELL	-92			353.810*		378.18 Profit of 34,793 on sale
2025-11-04	SELL	-184			362.610*		378.25 Profit of 69,598 on sale
2025-10-22	SELL	-46	388.350	392.550	392.130	EUR -18,038	378.20 Loss of -641 on sale
2025-10-21	SELL	-92	379.760	383.120	382.784	EUR -35,216	378.20 Loss of -422 on sale
2025-10-16	BUY	46	369.250	372.880	372.517	EUR 17,136	378.24
2025-10-14	SELL	-138	370.000	372.950	372.655	EUR -51,426	378.32 Profit of 782 on sale
2025-10-13	SELL	-184	364.920	370.600	370.032	EUR -68,086	378.38 Profit of 1,537 on sale
2025-09-25	BUY	46	368.570	369.380	369.299	EUR 16,988	378.63
2025-09-24	SELL	-690	371.220	374.180	373.884	EUR -257,980	378.66 Profit of 3,298 on sale
2025-09-18	BUY	46	377.840	378.150	378.119	EUR 17,393	378.67
2025-09-17	BUY	46	376.880	381.190	380.759	EUR 17,515	378.68
2025-08-19	SELL	-92	389.940	390.300	390.264	EUR -35,904	378.53 Loss of -1,079 on sale
2025-08-15	SELL	-46	381.910	383.140	383.017	EUR -17,619	378.50 Loss of -208 on sale
2025-08-13	SELL	-230	378.950	379.330	379.292	EUR -87,237	378.50 Loss of -183 on sale
2025-08-12	SELL	-598	376.610	379.170	378.914	EUR -226,591	378.51 Loss of -244 on sale
2025-08-07	SELL	-690	376.370	381.340	380.843	EUR -262,782	378.52 Loss of -1,605 on sale
2025-08-05	BUY	46	380.860	382.830	382.633	EUR 17,601	378.52
2025-07-31	BUY	138	392.730	401.990	401.064	EUR 55,347	378.45
2025-07-28	BUY	46	400.690	404.140	403.795	EUR 18,575	378.09
2025-07-25	SELL	-92	403.530	403.790	403.764	EUR -37,146	377.95 Loss of -2,374 on sale
2025-07-24	BUY	46	396.660	402.630	402.033	EUR 18,494	377.85
2025-07-18	BUY	46	389.400	393.000	392.640	EUR 18,061	377.51
2025-07-14	SELL	-46	391.460	392.950	392.801	EUR -18,069	377.22 Loss of -717 on sale
2025-07-08	SELL	-92	389.500	393.730	393.307	EUR -36,184	376.96 Loss of -1,504 on sale
2025-07-02	BUY	276	391.810	396.820	396.319	EUR 109,384	376.56
2025-06-24	SELL	-92	386.460	388.120	387.954	EUR -35,692	376.10 Loss of -1,090 on sale
2025-06-23	SELL	-46	379.160	379.490	379.457	EUR -17,455	376.08 Loss of -155 on sale
2025-06-20	BUY	426	375.560	377.900	377.666	EUR 160,886	376.09
2025-06-12	SELL	-138	380.490	381.590	381.480	EUR -52,644	376.11 Loss of -741 on sale
2025-06-11	SELL	-243	381.080	385.420	384.986	EUR -93,552	376.08 Loss of -2,164 on sale
2025-06-06	BUY	46	383.890	388.690	388.210	EUR 17,858	375.93
2025-06-02	SELL	-138	380.860	381.070	381.049	EUR -52,585	375.77 Loss of -728 on sale
2025-05-29	SELL	-46	382.350	384.660	384.429	EUR -17,684	375.68 Loss of -402 on sale
2025-05-27	BUY	46	383.780	385.400	385.238	EUR 17,721	375.59
2025-05-23	BUY	46	376.620	379.530	379.239	EUR 17,445	375.58
2025-05-21	SELL	-138	379.750	388.620	387.733	EUR -53,507	375.53 Loss of -1,684 on sale
2025-05-15	BUY	184	392.200	392.630	392.587	EUR 72,236	375.04
2025-05-14	SELL	-276	386.320	388.020	387.850	EUR -107,047	374.95 Loss of -3,560 on sale
2025-05-13	SELL	-552	387.530	390.460	390.167	EUR -215,372	374.86 Loss of -8,449 on sale
2025-05-07	SELL	-138	384.060	384.580	384.528	EUR -53,065	374.59 Loss of -1,372 on sale
2025-05-02	SELL	-46	378.220	379.330	379.219	EUR -17,444	374.48 Loss of -218 on sale
2025-04-29	SELL	-138	370.920	372.320	372.180	EUR -51,361	374.52 Profit of 323 on sale
2025-04-24	BUY	46	361.050	361.330	361.302	EUR 16,620	374.77
2025-04-22	BUY	184	348.120	349.450	349.317	EUR 64,274	375.14
2025-04-16	BUY	46	346.670	352.580	351.989	EUR 16,191	376.18
2025-04-15	BUY	46	346.800	355.390	354.531	EUR 16,308	376.43
2025-04-11	BUY	92	350.280	353.100	352.818	EUR 32,459	376.86
2025-04-09	BUY	230	362.970	364.400	364.257	EUR 83,779	377.24
2025-04-08	BUY	690	337.370	357.470	355.460	EUR 245,267	377.60
2025-04-07	SELL	-322	345.340	357.590	356.365	EUR -114,750	377.89 Profit of 6,931 on sale
2025-04-04	SELL	-690	345.800	362.070	360.443	EUR -248,706	378.18 Profit of 12,242 on sale
2025-04-02	SELL	-138	377.460	378.350	378.261	EUR -52,200	378.19 Loss of -10 on sale
2025-04-01	SELL	-46	373.300	374.040	373.966	EUR -17,202	378.24 Profit of 196 on sale
2025-03-31	SELL	-92	372.250	374.200	374.005	EUR -34,408	378.29 Profit of 395 on sale
2025-03-28	BUY	92	364.500	368.510	368.109	EUR 33,866	378.42
2025-03-25	BUY	138	372.870	379.040	378.423	EUR 52,222	378.69
2025-03-24	BUY	184	374.270	377.230	376.934	EUR 69,356	378.73
2025-03-21	SELL	-92	371.110	374.790	374.422	EUR -34,447	378.81 Profit of 404 on sale
2025-03-20	BUY	92	374.220	378.260	377.856	EUR 34,763	378.86
2025-03-19	BUY	184	378.050	380.890	380.606	EUR 70,032	378.87
2025-03-17	SELL	-138	373.490	376.690	376.370	EUR -51,939	378.95 Profit of 356 on sale
2025-03-14	SELL	-92	369.530	371.760	371.537	EUR -34,181	379.05 Profit of 691 on sale
2025-03-13	SELL	-276	363.660	367.280	366.918	EUR -101,269	379.21 Profit of 3,394 on sale
2025-03-11	SELL	-322	365.290	369.520	369.097	EUR -118,849	379.53 Profit of 3,361 on sale
2025-03-10	SELL	-184	370.120	377.090	376.393	EUR -69,256	379.64 Profit of 597 on sale
2025-03-06	SELL	-184	382.310	393.470	392.354	EUR -72,193	379.61 Loss of -2,345 on sale
2025-03-05	SELL	-276	395.690	398.000	397.769	EUR -109,784	379.43 Loss of -5,062 on sale
2025-03-04	SELL	-368	389.920	396.440	395.788	EUR -145,650	379.31 Loss of -6,065 on sale
2025-02-28	SELL	-230	386.190	393.820	393.057	EUR -90,403	379.04 Loss of -3,223 on sale
2025-02-26	BUY	92	391.740	396.670	396.177	EUR 36,448	378.77
2025-02-24	BUY	92	387.920	390.280	390.044	EUR 35,884	378.52
2025-02-21	BUY	46	382.780	387.520	387.046	EUR 17,804	378.46
2025-02-20	SELL	-138	386.410	388.000	387.841	EUR -53,522	378.36 Loss of -1,308 on sale
2025-02-14	SELL	-46	385.180	391.490	390.859	EUR -17,980	377.95 Loss of -594 on sale
2025-02-13	SELL	-598	388.370	388.800	388.757	EUR -232,477	377.81 Loss of -6,548 on sale
2025-02-12	SELL	-46	385.630	389.730	389.320	EUR -17,909	377.70 Loss of -535 on sale
2025-02-06	SELL	-184	396.070	400.250	399.832	EUR -73,569	376.83 Loss of -4,232 on sale
2025-02-05	BUY	46	399.090	399.850	399.774	EUR 18,390	376.51
2025-02-04	BUY	322	392.390	393.070	393.002	EUR 126,547	376.27
2025-01-29	SELL	-322	391.070	396.710	396.146	EUR -127,559	375.34 Loss of -6,701 on sale
2025-01-28	BUY	92	395.150	406.190	405.086	EUR 37,268	375.02
2025-01-24	BUY	46	394.310	394.680	394.643	EUR 18,154	374.28
2025-01-22	BUY	92	390.490	395.000	394.549	EUR 36,299	373.67
2025-01-16	BUY	92	381.790	381.820	381.817	EUR 35,127	372.75
2025-01-15	BUY	46	368.610	370.050	369.906	EUR 17,016	372.82
2025-01-10	BUY	92	365.660	368.820	368.504	EUR 33,902	373.41
2025-01-02	BUY	138	358.720	362.480	362.104	EUR 49,970	374.11
2024-12-31	BUY	92	360.050	364.580	364.127	EUR 33,500	374.42
2024-12-27	BUY	46	367.110	369.670	369.414	EUR 16,993	374.86
2024-12-20	BUY	138	364.600	364.810	364.789	EUR 50,341	375.57
2024-12-19	BUY	46	357.140	363.060	362.468	EUR 16,674	376.04
2024-12-18	SELL	-46	359.170	371.920	370.645	EUR -17,050	376.48 Profit of 269 on sale
2024-12-17	BUY	92	370.810	374.570	374.194	EUR 34,426	376.64
2024-12-13	BUY	46	374.600	376.490	376.301	EUR 17,310	376.81
2024-12-11	SELL	-253	376.160	386.630	385.583	EUR -97,553	376.83 Loss of -2,216 on sale
2024-12-10	BUY	46	382.680	385.560	385.272	EUR 17,723	376.65
2024-12-06	SELL	-92	385.020	389.990	389.493	EUR -35,833	376.23 Loss of -1,220 on sale
2024-12-05	BUY	46	382.450	388.710	388.084	EUR 17,852	376.03
2024-12-04	SELL	-368	389.760	392.210	391.965	EUR -144,243	375.55 Loss of -6,039 on sale
2024-12-03	BUY	138	390.970	391.900	391.807	EUR 54,069	375.00
2024-12-02	BUY	230	389.630	394.140	393.689	EUR 90,548	374.46
2024-11-27	BUY	46	388.140	391.400	391.074	EUR 17,989	372.58
2024-11-26	BUY	322	389.710	389.950	389.926	EUR 125,556	371.84
2024-11-21	BUY	138	390.140	390.370	390.347	EUR 53,868	369.62
2024-11-20	BUY	92	385.680	390.000	389.568	EUR 35,840	368.78
2024-11-19	BUY	46	388.680	392.310	391.947	EUR 18,030	367.67
2024-11-18	BUY	92	389.400	398.200	397.320	EUR 36,553	366.39
2024-11-12	BUY	184	387.110	388.120	388.019	EUR 71,395	365.10
2024-11-11	BUY	92	378.860	381.540	381.272	EUR 35,077	364.18
2024-11-08	BUY	368	375.960	377.830	377.643	EUR 138,973	363.34
2024-11-07	BUY	322	369.830	370.340	370.289	EUR 119,233	362.84
2024-11-06	BUY	368	369.020	376.040	375.338	EUR 138,124	362.32
2024-11-05	SELL	-92	369.860	370.290	370.247	EUR -34,063	361.64 Loss of -792 on sale
2024-11-04	BUY	92	366.900	369.690	369.411	EUR 33,986	361.11
2024-11-01	BUY	322	367.150	367.760	367.699	EUR 118,399	360.44
2024-10-28	BUY	230	356.010	356.520	356.469	EUR 81,988	361.85
2024-10-25	BUY	506	352.820	361.600	360.722	EUR 182,525	364.10
2024-10-23	SELL	-46	363.240	366.970	366.597	EUR -16,863	366.63 Profit of 2 on sale
2024-10-21	BUY	46	367.250	370.970	370.598	EUR 17,048	0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SYK

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer